Results
|
1.
|
|
|
2.
|
Evaluation of lapatinib as a component of neoadjuvant therapy for HER2+ operable breast cancer: NSABP protocol B-41. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(18_suppl):LBA506, 2012 Jun 20
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky A, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE, Kuebler JP, Mamounas EP, Margolese RG, Paik S, Rastogi P, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
3.
|
Locoregional recurrence (LRR) after neoadjuvant chemotherapy (NAC): Pooled-analysis results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC). MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(26_suppl):61, 2014 Sep 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bogaerts J, Bonnefoi HR, Cameron DA, Cortazar P, Costantino JP, Eidtmann H, Gerber B, Geyer CE, Gianni L, Loibl S, Mehta K, Rastogi P, Sridhara R, Swain SM, Untch M, Valagussa P, Von Minckwitz G, Wolmark N, Zhang L
|
|
4.
|
|
|
5.
|
|
|
6.
|
|